EQS-Adhoc: IGEA announces annual general meeting resolutions


03.07.20 22:40
Meldung
 

EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Miscellaneous
IGEA announces annual general meeting resolutions

03-Jul-2020 / 22:35 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.


IGEA announces annual general meeting resolutions

Hoofddorp, the Netherlands, 3 July 2020. IGEA Pharma N.V. (SIX: IGPH) today announced that its shareholders followed the recommendations of the company. The minutes of the second annual general meeting is available at https://www.igeapharma.nl/category/information-for-shareholders/

***

About IGEA
IGEA Pharma N.V. focuses on health-tech and med-tech products and devices. Health-tech products are exclusively preventative. IGEA commercializes an Alzheimer's prevention set (which includes 'Alz1', an at-home lab test kit to measure non-bound copper in the blood and a natural dietary supplement branded 'Alz1 Tab' designed to reduce blood heavy metals content), and intends to launch a diabetes type II prevention set in 2020. Non-ceruloplasmin bound copper is an expected Alzheimer's and diabetes type II associated biomarker. Controlling non-bound copper can contribute to reduce the risk of Alzheimer's and diabetes type II. Since 2020, IGEA furthermore commercializes a COVID-19 rapid test for the detection of IgM and IgG SARC-CoV-2 related antibodies. Med-tech products focuses on selected solutions and specialities. IGEA commercializes dry aerosol generators for air and inanimate environmental surfaces sanitization and air sterilization and purification devices and expects to start commercializing medical bags and other polymeric based specialty devices for medical use during 2020.

IGEA is listed on the SIX Swiss Exchange (ticker IGPH) and is headquartered in Hoofddorp, the Netherlands. Find out more at www.igeapharma.nl

Contacts
Vincenzo Moccia, CEO, +39 340 583 09 33, moccia@igeapharma.com
Patrick Pozzorini, CFO, +41 79 314 41 43, pozzorini@igeapharma.com

Disclaimer
This document constitutes neither an offer to buy nor to subscribe securities and neither this document nor any part of it should form the basis of any investment decision in IGEA.

The information contained in this press release has been carefully prepared. However, IGEA bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. IGEA does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons.

This publication may contain specific forward-looking statements and assessments or intentions concerning IGEA and its business. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of IGEA and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. IGEA assumes no responsibility to update forward-looking statements or to adapt them to future events or developments, except as may be required by law.


Additional features:


File: 20200703 igea nv_press release

End of ad hoc announcement
Language: English
Company: IGEA Pharma N.V.
Siriusdreef 17
2123 WT Hoofddorp
Netherlands
Phone: +31 23 568 9494
E-mail: info@igearesearch.com
Internet: www.igeapharma.nl
ISIN: NL0012768675
Listed: SIX Swiss Exchange
EQS News ID: 1086471

 
End of Announcement EQS Group News Service

1086471  03-Jul-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1086471&application_name=news&site_id=ariva


 

Breaking News


Kurs- und weitere Informationen zum Thema:

IGEA Pharma N

Aktuelle Diskussionen zum Thema:

IGEA Pharma - COVID-19-... (06.05.20)

Aktuelle Nachrichten zum Unternehmen:

Igea Pharma: Wie ist das denn je. (26.06.20)
Igea Pharma: Was jetzt noch rich. (20.06.20)
Igea Pharma: Was ist jetzt angeb. (13.06.20)
Igea Pharma: Müssen Sie sich jetz. (23.05.20)
Igea Pharma: Wohin geht die Reis. (24.01.20)

Alle Nachrichten zum Unternehmen

Aktuelle Analysen zu den Unternehmen:

IGEA Pharma N
Weitere Meldungen
 
03.07 EQS-Adhoc: IGEA announce.
03.07 Ad hoc: Commerzbank: Mart.
02.07 Ad hoc: Heliad Equity Partn.
02.07 Ad hoc: Northern Data ents.
02.07 Ad hoc: PAION GIBT MAR.
02.07 Ad hoc: DE-VAU-GE Gesun.
02.07 Ad hoc: JENOPTIK AG: Jen.
02.07 Ad hoc: SPORTTOTAL AG.
02.07 Ad hoc: ADO Properties S.
02.07 EQS-Adhoc: Leonteq gibt Zu.
02.07 EQS-Adhoc: Achiko schliess.
01.07 Ad hoc: Backbone Technolog.
01.07 Ad hoc: Zustimmung zum b.
01.07 Ad hoc: Fernheizwerk Neukö.
01.07 Ad hoc: Villeroy & Boch A.
01.07 Ad hoc: OHB SE: OHB-Ang.
01.07 Ad hoc: REO Spanien Proje.
01.07 Ad hoc: home24 SE: home2.
30.06 Ad hoc: STS Group AG: A.
30.06 Ad hoc: Airbus plans to fur.
30.06 EQS-Adhoc: Leclanché schlie.
30.06 Ad hoc: Wirecard AG: Künd.
30.06 EQS-Adhoc: Generalversamm.
30.06 Ad hoc: UmweltBank Aktien.
30.06 EQS-Adhoc: Mobimo Holding.
30.06 Ad hoc: SPORTTOTAL AG.
30.06 Ad hoc: FC Gelsenkirchen-S.
30.06 Ad hoc: SPORTTOTAL AG.
30.06 Ad hoc: DATRON AG: Vor.
30.06 Ad hoc: The Naga Group A.


Umfrage
 
Welche Social Networks nutzen Sie meistens?
Facebook
keine
Twitter
Xing
Linked in
Youtube
myspace
Google+
Wikipedia
andere


Stimmen: 64735 , Ergebnis


Kurssuche
Status: nicht eingeloggt

Registrieren | Passwort vergessen?
 
 
Im Bereich Nachrichten:
Silber: Jetzt Gewinne sichern!
Experte: Stefan Hofmann, STOCK-WORLD
Kolumnen
NEUGESTALTUNG DES ...
Benjamin Summa, pro aurum (11:46)
Experte: Benjamin Summa, pro aurum
S&P500 - Wir bereiten ...
Philip Hopf, Hopf Klinkmüller Capital. (11:17)
Experte: Philip Hopf, Hopf Klinkmüller Capital Management K.
Fonds: Mit Tech- und ...
Redaktion boerse-frankf., Deutsche Börse AG (11:06)
Experte: Redaktion boerse-frankfurt.de, Deutsche Börse AG
Pinocchio in Aktion: Fed-...
Claus Vogt, (10:53)
Experte: Claus Vogt,
Singulus: Finger Weg!
Robert Sasse, (10:17)
Experte: Robert Sasse,
Im Fokus: Asien
Cornelia Frey, Börse Stuttgart AG (10:07)
Experte: Cornelia Frey, Börse Stuttgart AG
Wirecard: Schäffler fordert ...
Frank Schäffler, (10:01)
Experte: Frank Schäffler,
Deutsche Cannabis: Das ...
Volker Gelfarth, (09:23)
Experte: Volker Gelfarth,
Siebenjährige Symrise-...
Börse Stuttgart AG, (09:15)
Experte: Börse Stuttgart AG,
Wochenausblick: DAX im ...
HypoVereinsbank onema., (09:08)
Experte: HypoVereinsbank onemarkets,
Irgendjemand ist hier ...
Bernd Niquet, Autor (08:32)
Experte: Bernd Niquet, Autor
DOW DAX testet den ...
Thomas Heydrich, Systemstradings.de (03.07.20)
Experte: Thomas Heydrich, Systemstradings.de
Niquet's World
Neues vom Portal
 
Was sind Casino-Finanzen?
Letzte Börsen-Meldung
 
Letzte Börsen-Analyse
 
Top-Klicks News
 
Top-Klicks Analysen